Search
EHA joins ESMO in calling for EU action on shortages of essential medicines
EHA joins ESMO in calling for EU action on shortages of essential medicines
The European Hematology Association (EHA) has endorsed and signed a collective Call to Action, prepared by the European Society for Medical Oncology (ESMO), on shortages of inexpensive, essential…
Selected EMA news
March 2025New medicines recommended for approval
Lynozyfic (linvoseltamab)
Treatment of refractory multiple myeloma (a cancer of the bone marrow)
New information on approved medicines
Calquence (acalabrutinib) - new indication
Treatment of blood cancer
Columvi (glofitamab) - new indication
Treatment of blood cancer
Darzalex (daratumumab) - change of indication
Treatment…
Pieter Sonneveld appointed Officer in the Order of Orange-Nassau
The EHA Board congratulates former EHA President Professor Pieter Sonneveld on his appointment as an Officer of the Order of Orange-Nassau by His Majesty King Willem-Alexander of the Netherlands.
Read moreMulti-center acute myeloid leukemia study
An SWG Grant-supported project initiated by EHA's SWG on Acute Myeloid Leukemia.
Read morePosition of EHA on Research Funding
The challenge
The cost of biomedical research is great, but the cost of disease is immense. An ageing population and expensive innovations in medicine put an increasing burden on already stressed healthcare budgets.
Publications
The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review
Salek, S. ; Ionova, T. ; Oliva, E. N. ; Andreas, M. ; Skoetz, N. ; Kreuzberger, N. ; Laane, E.
SWG Educational Activities
Social and public activitiesSince 2020, Prof Hermann Einsele has been a Councilor to the EHA Board. Scientific activitiesFifth European CAR T-cell meetingDateFebruary 9–11, 2023. LocationRotterdam, The Netherlands.
Read more